Preferences
Related Series
Related Segments
Latin America EHR 2024
A Look at Market Share & Vendor Performance
EHR purchasing in Latin America has fluctuated over the last few years, initially declining at the onset of the pandemic before rising in 2023, when the total number of acute care beds impacted by an EHR purchase decision was over 62% higher than in 2021. This report provides an update on which vendors are gaining market share and which are best meeting customers’ needs. Altogether, market share data and customer satisfaction feedback were collected from 97 respondents, representing 75 separate organizations in 12 countries and territories. In this report, market share data for Latin America is examined first, followed by customer satisfaction data (when available) in Brazil and in other countries throughout the region, collectively referred to as “other Latin American countries and the Caribbean.”
If you don't have a login, getting started is easy.
Key Findings:
- MV & Philips Continue to Grow in Brazil via New Contracts & Migrations; NTT DATA & Dedalus Increase Hospital Count through Public Health Contracts
- MV & Philips Are Highest Rated in Brazil—MV Customers Note Steady Improvements; Philips’ Customer Satisfaction Remains Consistent
- Pixeon Delivers Value to Smaller Hospitals despite Customer Concerns about Support & Upgrades
- InterSystems Customers Satisfied with Product but Experience Support Issues; Oracle Health i.s.h.med Customers Struggle Post-Acquisition
- MV Has Strong Performance outside of Brazil; Philips Customer Satisfaction Significantly Declines
Writer
Sarah Brown
Designer
Breanne Hunter
Project Manager
Sydney Toomer
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.